Concepts (64)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pituitary Adenylate Cyclase-Activating Polypeptide | 6 | 2023 | 101 | 2.340 |
Why?
|
Septal Nuclei | 2 | 2023 | 85 | 0.870 |
Why?
|
Stress, Psychological | 3 | 2023 | 4305 | 0.540 |
Why?
|
Adaptation, Psychological | 1 | 2022 | 2570 | 0.390 |
Why?
|
Pituitary-Adrenal System | 2 | 2022 | 540 | 0.270 |
Why?
|
Hypothalamo-Hypophyseal System | 2 | 2022 | 686 | 0.260 |
Why?
|
Rats, Wistar | 2 | 2019 | 1857 | 0.230 |
Why?
|
Anxiety | 4 | 2023 | 4409 | 0.210 |
Why?
|
Rats | 5 | 2023 | 23696 | 0.190 |
Why?
|
Behavior, Animal | 3 | 2019 | 1848 | 0.190 |
Why?
|
Corticotropin-Releasing Hormone | 1 | 2022 | 360 | 0.190 |
Why?
|
Hyperalgesia | 1 | 2023 | 500 | 0.170 |
Why?
|
Vasoactive Intestinal Peptide | 1 | 2019 | 179 | 0.160 |
Why?
|
Phenotype | 1 | 2015 | 16261 | 0.150 |
Why?
|
Corpus Striatum | 1 | 2023 | 1220 | 0.140 |
Why?
|
Depression | 2 | 2015 | 7826 | 0.140 |
Why?
|
Dopamine | 1 | 2023 | 1572 | 0.130 |
Why?
|
Infusions, Intraventricular | 1 | 2015 | 34 | 0.130 |
Why?
|
Receptor, Melanocortin, Type 4 | 1 | 2016 | 129 | 0.130 |
Why?
|
Alcoholism | 1 | 2023 | 1922 | 0.110 |
Why?
|
Obsessive-Compulsive Disorder | 1 | 2022 | 1470 | 0.110 |
Why?
|
Animals | 10 | 2023 | 166558 | 0.100 |
Why?
|
Neurotransmitter Agents | 1 | 2016 | 649 | 0.100 |
Why?
|
Anorexia | 1 | 2012 | 155 | 0.100 |
Why?
|
Tryptophan Hydroxylase | 1 | 2010 | 91 | 0.090 |
Why?
|
Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I | 2 | 2023 | 51 | 0.090 |
Why?
|
Chronic Disease | 1 | 2023 | 9124 | 0.080 |
Why?
|
Fluoxetine | 1 | 2012 | 753 | 0.080 |
Why?
|
Citalopram | 1 | 2010 | 400 | 0.080 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 2010 | 498 | 0.070 |
Why?
|
Mice | 6 | 2023 | 80251 | 0.070 |
Why?
|
Benzodiazepines | 1 | 2012 | 1114 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2015 | 10750 | 0.070 |
Why?
|
Neurons | 1 | 2023 | 9292 | 0.060 |
Why?
|
Synapses | 2 | 2023 | 1738 | 0.050 |
Why?
|
Motor Activity | 1 | 2012 | 2670 | 0.050 |
Why?
|
Mesencephalon | 1 | 2023 | 327 | 0.050 |
Why?
|
Ethanol | 1 | 2023 | 1316 | 0.040 |
Why?
|
Receptors, Melanocortin | 1 | 2016 | 24 | 0.040 |
Why?
|
Melanocyte-Stimulating Hormones | 1 | 2016 | 25 | 0.040 |
Why?
|
Movement | 1 | 2023 | 1466 | 0.030 |
Why?
|
Corticosterone | 1 | 2016 | 296 | 0.030 |
Why?
|
Amygdala | 1 | 2022 | 1329 | 0.030 |
Why?
|
Motivation | 1 | 2023 | 1966 | 0.030 |
Why?
|
Fear | 1 | 2022 | 1440 | 0.030 |
Why?
|
Male | 4 | 2022 | 351420 | 0.030 |
Why?
|
Alcohol Drinking | 1 | 2023 | 3962 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2023 | 21600 | 0.020 |
Why?
|
Swimming | 1 | 2010 | 205 | 0.020 |
Why?
|
Locomotion | 1 | 2010 | 379 | 0.020 |
Why?
|
Mice, Inbred Strains | 1 | 2010 | 1761 | 0.020 |
Why?
|
Running | 1 | 2012 | 474 | 0.020 |
Why?
|
Species Specificity | 1 | 2010 | 2411 | 0.020 |
Why?
|
Eating | 1 | 2012 | 1539 | 0.020 |
Why?
|
Anxiety Disorders | 1 | 2016 | 2683 | 0.020 |
Why?
|
Emotions | 1 | 2016 | 2671 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2010 | 4883 | 0.010 |
Why?
|
Disease Models, Animal | 2 | 2012 | 17869 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2010 | 6102 | 0.010 |
Why?
|
Body Weight | 1 | 2012 | 4606 | 0.010 |
Why?
|
Survival Rate | 1 | 2012 | 12645 | 0.010 |
Why?
|
Time Factors | 1 | 2010 | 39622 | 0.010 |
Why?
|
Female | 2 | 2012 | 382450 | 0.000 |
Why?
|
Humans | 1 | 2022 | 746630 | 0.000 |
Why?
|
Concepts
(64)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(3)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_